CSIMarket



Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

LLY's Net Income Growth by Quarter and Year

Eli Lilly And's Net Income results by quarter and year




LLY Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,726.10 2,116.80 1,495.70
III Quarter September - 1,110.10 1,208.40 1,253.90
II Quarter June - 1,390.20 1,412.00 1,327.20
I Quarter March 1,902.90 1,355.30 1,456.50 4,241.60
FY   1,902.90 5,581.70 6,193.70 8,318.40



LLY Net Income first quarter 2022 Y/Y Growth Comment
Eli Lilly And Company achieved in the first quarter 2022, above Company average Net Income rise of 40.4% year on year, to $ 1,902.90 millions.

According to the results reported in the first quarter 2022, Eli Lilly And Company achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Eli Lilly And Company' s Net Income jump of 40.4% ranks overall at the positon no. 138 in the first quarter 2022.




LLY Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -18.46 % 41.53 % 383.26 %
III Quarter September - -8.13 % -3.63 % 9.08 %
II Quarter June - -1.54 % 6.39 % -
I Quarter March 40.4 % -6.95 % -65.66 % 248.41 %
FY   - -9.88 % -25.54 % 244.23 %

Financial Statements
Eli Lilly And's first quarter 2022 Net Income $ 1,902.90 millions LLY's Income Statement
Eli Lilly And's first quarter 2021 Net Income $ 1,355.30 millions Quarterly LLY's Income Statement
New: More LLY's historic Net Income Growth >>


LLY Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 55.49 % 75.17 % 19.28 %
III Quarter September - -20.15 % -14.42 % -5.52 %
II Quarter June - 2.58 % -3.06 % -68.71 %
I Quarter March 10.24 % -35.97 % -2.62 % 1270.47 %
FY (Year on Year)   - -9.88 % -25.54 % 244.23 %




Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #9
Overall #138

Net Income Y/Y Growth Statistics
High Average Low
125.15 % 3.92 % -36.59 %
(Mar 31 2019)   (Sep. 30. 2008)
Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #9
Overall #138
Net Income Y/Y Growth Statistics
High Average Low
125.15 % 3.92 % -36.59 %
(Mar 31 2019)   (Sep. 30. 2008)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Eli Lilly And's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
1270.47 % 25.84 % -84.86 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q Net Income Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average Net Income rise of 10.24% quarter on quarter, to $ 1,902.90 millions.

I. Quarter 2022 Eli Lilly And's results seem to be contradictory, albeit below the ordinary, yet it shows absolute improvement compare to the -35.97% in the I. Quarter a year ago.

Within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Net Income quarter on quarter growth. While Eli Lilly And's Net Income growth quarter on quarter, overall rank is 922.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #55
Overall #922
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #21
Healthcare Sector #55
Overall #922
Net Income Q/Q Growth Statistics
High Average Low
1270.47 % 25.84 % -84.86 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q Net Income Comment
Eli Lilly And Company achieved in the I. Quarter 2022 below company average Net Income rise of 10.24% quarter on quarter, to $ 1,902.90 millions.

Although the I. Quarter 2022 results were below the average of 25.84 %, that was still good story, as the current expension, transcends the -35.97% surge in the same quarter a year ago

Within Major Pharmaceutical Preparations industry 20 other companies have achieved higher Net Income quarter on quarter growth. While Eli Lilly And's Net Income growth quarter on quarter, overall rank is 922.


Eli Lilly And's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Income 12 Months Ending $ 6,129.30 $ 5,581.70 $ 5,972.40 $ 6,070.70 $ 6,092.50
Y / Y Net Income Growth (TTM) 0.6 % -9.88 % 7.17 % 8.06 % 10.11 %
Year on Year Net Income Growth Overall Ranking # 332 # 811 # 1213 # 1357 # 446
Seqeuential Net Income Change (TTM) 9.81 % -6.54 % -1.62 % -0.36 % -1.63 %
Seq. Net Income Growth (TTM) Overall Ranking # 138 # 894 # 205 # 1251 # 835




Cumulative Net Income growth Comment
Although Eli Lilly And's Annual Net Income growth year on year were below company's average 38.62% , Net Income announced in the Mar 31 2022 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 0.6% year on year, from -9.88% in Dec 31 2021. And, Eli Lilly And had the highest Net Income growth, in Major Pharmaceutical Preparations industry.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 332, from total ranking in previous quarter at 811.

Net Income TTM Q/Q Growth Statistics
High Average Low
125.15 %
3.92 %
-36.59 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 17
Overall # 332

Net Income TTM Y/Y Growth Statistics
High Average Low
1484.58 %
38.62 %
-79.77 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 9
S&P 500 # 138
Cumulative Net Income growth Comment
Although Eli Lilly And's Annual Net Income growth year on year were below company's average 38.62% , Net Income announced in the Mar 31 2022 period, show improvement in Net Income trend, to cumulative trailing twelve month growth of 0.6% year on year, from -9.88% in Dec 31 2021. And, Eli Lilly And had the highest Net Income growth, in Major Pharmaceutical Preparations industry.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 332, from total ranking in previous quarter at 811.

Net Income TTM Q/Q Growth Statistics
High Average Low
125.15 %
3.92 %
-36.59 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 17
Overall # 332

Net Income TTM Y/Y Growth Statistics
High Average Low
1484.58 %
38.62 %
-79.77 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 9
S&P 500 # 138




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
LLY's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for LLY's Competitors
Net Income Growth for Eli Lilly And's Suppliers
Net Income Growth for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons



Companies with similar Net Income rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2022
Repligen Corp59.47%$ 59.470 millions
Conmed Corporation51.88%$ 51.876 millions
Becton Dickinson And Company51.33%$ 51.333 millions
Iqvia Holdings Inc 49.77%$ 49.770 millions
Charles River Laboratories International inc 48.94%$ 48.942 millions
Co diagnostics Inc.48.31%$ 48.305 millions
Phibro Animal Health Corp45.46%$ 45.457 millions
Abcellera Biologics Inc 43.81%$ 43.808 millions
Medpace Holdings Inc 41.58%$ 41.576 millions
Eli Lilly And Company40.40%$ 40.404 millions
Abbott Laboratories36.48%$ 36.475 millions
Merck and Co Inc 35.37%$ 35.374 millions
Bio techne Corp32.47%$ 32.470 millions
The Pennant Group Inc 26.83%$ 26.835 millions
Abbvie Inc 26.39%$ 26.385 millions
Tenet Healthcare Corp26.13%$ 26.126 millions
Glucotrack Inc.20.91%$ 20.907 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JMSB's Profile

Stock Price

JMSB's Financials

Business Description

Fundamentals

Charts & Quotes

JMSB's News

Suppliers

JMSB's Competitors

Customers & Markets

Economic Indicators

JMSB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071